ELISA Kit for Amphiregulin (AREG)
AR; CRDGF; SDGF; Colorectum Cell-Derived Growth Factor; Schwannoma-Derived Growth Factor
- Product No.SEA006Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range15.6-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 5.8pg/mL.
- DownloadInstruction Manual
96T*5 96T*10 96T*100
Ensure in stock; if not, free redo!
For negotiated price and more details, please contact local distributors! US$ 488
For negotiated price and more details, please contact local distributors! US$ 2196
For negotiated price and more details, please contact local distributors! US$ 4148
For negotiated price and more details, please contact local distributors! US$ 34160
For negotiated price and more details, please contact local distributors!
This assay has high sensitivity and excellent specificity for detection of Amphiregulin (AREG).
No significant cross-reactivity or interference between Amphiregulin (AREG) and analogues was observed.
Matrices listed below were spiked with certain level of recombinant Amphiregulin (AREG) and the recovery rates were calculated by comparing the measured value to the expected amount of Amphiregulin (AREG) in samples.
|Matrix||Recovery range (%)||Average(%)|
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Amphiregulin (AREG) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Amphiregulin (AREG) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Amphiregulin (AREG) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
|Pre-coated, ready to use 96-well strip plate||1||Plate sealer for 96 wells||4|
|Detection Reagent A||1×120µL||Assay Diluent A||1×12mL|
|Detection Reagent B||1×120µL||Assay Diluent B||1×12mL|
|TMB Substrate||1×9mL||Stop Solution||1×6mL|
|Wash Buffer (30 × concentrate)||1×20mL||Instruction manual||1|
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
|Onkologie||Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological Characteristics Karger: 315380|
|Br J Cancer.||Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer. Pubmed:24800946|
|Cancer Sci||Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer PubMed: 25707609|
|J Cancer Res Clin Oncol||Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer PubMed: 26195282|
|Oncotarget.||Serum level of hepatocyte growth factor is a novel marker of predicting theoutcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer Pubmed:26716644|
|Catalog No.||Related products for research use of Mus musculus (Mouse) Organism species||Applications (RESEARCH USE ONLY!)|
|RPA006Mu02||Recombinant Amphiregulin (AREG)||Positive Control; Immunogen; SDS-PAGE; WB.|
|RPA006Mu01||Recombinant Amphiregulin (AREG)||Positive Control; Immunogen; SDS-PAGE; WB.|
|PAA006Mu01||Polyclonal Antibody to Amphiregulin (AREG)||WB; IHC; ICC; IP.|
|PAA006Mu02||Polyclonal Antibody to Amphiregulin (AREG)||WB; IHC; ICC; IP.|
|SEA006Mu||ELISA Kit for Amphiregulin (AREG)||Enzyme-linked immunosorbent assay for Antigen Detection.|
|SCA006Mu||CLIA Kit for Amphiregulin (AREG)||Chemiluminescent immunoassay for Antigen Detection.|